AX-2025-019911 · PEG-MGF · HJ lot HJ-2507-S5943

Section 1

Results

Measured against the index acceptance specification for the growth-hormone axis peptides class. A specification is a decision the index made; a result is a measurement. See where each threshold came from.

Parameter	Method	Result	Unit	Index spec
Purity	RP-HPLC, 30 min gradient, 214 nm	97.65	% area	≥ 92.0	PASS
Total impurities	RP-HPLC, sum of reported peaks	2.35	% area	≤ 8.0	PASS
Largest single impurity	RP-HPLC — free MGF (unconjugated)	0.90	% area	≤ 1.00	PASS
Identity — theoretical monoisotopic mass	calculated from molecular formula	7894.0000	Da	—	NOT TESTED
Identity — observed monoisotopic mass	LC-MS, high resolution (ESI-TOF/QTOF)	7893.9779	Da	—	NOT TESTED
Mass accuracy	observed vs theoretical	-2.8	ppm	± 15	PASS
Total peptide content	by difference from the gravimetric mass balance	90.23	%w/w	—	NOT TESTED
Target-compound content	total peptide content × purity	88.11	%w/w	—	NOT TESTED
Gross fill (as weighed)	five-place balance, under nitrogen	5.21	mg	5 mg declared	NOT TESTED
Recovered target peptide	gross fill × target content	4.591	mg	5 mg claim	NOT TESTED
Recovery against label claim	recovered ÷ claim	91.8	%	90.0 – 110.0	PASS
Water content	Karl Fischer, coulometric, duplicate	7.07	%	≤ 9.0	PASS
Counter-ion (acetate)	anion-exchange ion chromatography	1.87	%	≤ 12.0	PASS
Residual solvent + inorganic residue	estimated — see /methods/residual-solvents-q3c/	0.83	%	—	NOT TESTED
Endotoxin	not ordered on this submission	not determined	—	≤ 5.0	NOT TESTED
Sterility	not ordered on this submission	not determined	—	no growth	NOT TESTED
Appearance	visual, diffuse light, black and white background	White lyophilised cake, intact	—	white to off-white intact cake	PASS
Reconstitution clarity	reconstituted per submitter procedure	Faint haze, clearing on standing	—	clear, no visible particulates	FAIL
pH (reconstituted, 1 mg/mL)	potentiometric, two-point calibration	4.85	—	2.5 – 8.0	PASS
Retention time (observed)	RP-HPLC, 30 min gradient	17.34	min	17.24 ± 0.80 (normalised)	PASS
Peak asymmetry (10 % height)	Ph. Eur. 2.2.46	1.35	—	0.80 – 1.50	PASS
Plate count, main peak	N = 5.54 (t/w½)²	48,754	—	≥ 20,000	PASS
Resolution to nearest impurity	vs hydrolysed linker	2.24	—	no index criterion	REPORTED

Section 2

Chromatogram and peak integration

The figure is drawn from the table. It is not an independent illustration — if a number in the table changed, the trace would change with it.

Figure 1. RP-HPLC trace, 30 min gradient, 214 nm. Drawn from the peak-integration table below: peak positions are the reported retention times, peak areas are the reported area percentages, peak widths follow the reported plate count of 48,754, and skew follows the reported asymmetry factor of 1.35. Baseline noise is seeded from the report ID and is illustrative. The lower panel is the same trace at a stated vertical expansion with the slow gradient drift subtracted, because at full scale a 0.90 % impurity against a 97.65 % main peak is a line two pixels tall; the main peak runs off-scale there by design.

#	Peak	RT	Area (µV·s)	% area	Δ mass (Da)
1	PEG-MGF — main peak	17.34	4,746,093	97.65	—
2	free MGF (unconjugated)	11.72	43,743	0.90	-5007.488
3	free mPEG	19.76	40,827	0.84	-2886.512
4	di-PEGylated species	19.19	16,039	0.33	+5000.000
5	hydrolysed linker	16.62	13,609	0.28	+18.011
Closure check — purity + Σ impurities				100.00	CLOSES

Reporting threshold 0.05 % area. Peaks below it are not reported and are therefore excluded from the total, which overstates purity by their sum — see peak integration.

Section 3

Mass spectrum and identity

Theoretical monoisotopic mass 7894.0000 Da, computed from conjugate (24-mer + 5 kDa mPEG). All ppm figures on this site are against monoisotopic values — see why that matters.

Figure 2. ESI charge-state envelope, high-resolution instrument. Sticks are placed at m/z = (M + z × 1.007276)/z for the observed neutral mass of 7893.9779 Da. Sodium (+21.982/z) and potassium (+37.956/z) adducts are shown where the parent charge state exceeds 25 % relative abundance; they are adducts of the same molecule and are not impurities.

Charge	Theoretical m/z	Observed m/z	Δ m/z	Rel. abundance (%)
10+	790.4073	790.4051	-0.0022	8.8
9+	878.1184	878.1159	-0.0025	53.1
8+	987.7573	987.7545	-0.0028	100.0
7+	1128.7216	1128.7184	-0.0032	57.7
6+	1316.6739	1316.6703	-0.0036	7.9

Section 4

Gravimetric mass balance

Water, counter-ion, residual and total peptide content are exhaustive and mutually exclusive categories. They must account for 100 % of the cake mass. The index closes this to within 0.02 pp and the build asserts it.

Component	Determination	%w/w of cake
Water	Karl Fischer	7.07
Counter-ion (acetate)	ion chromatography	1.87
Residual solvent + inorganic residue	estimated	0.83
Total peptide content	by difference	90.23
Total		100.00 CLOSES

Supplier certificate, as declared

The supplier's own figures for this lot, beside the independent measurement. Divergence is assessed against the batch median, not against this single report — see rule AX-R05.

Figure	Supplier COA	This report	Index note
Purity (% area)	98.07	97.65	divergence -0.09 pp vs batch median
Total impurities (% area)	1.93	2.35
Largest single impurity (% area)	not stated	0.90
Water (%)	5.3	7.07
Counter-ion (%)	not stated	1.87
Peptide content (%w/w)	not stated	90.23
Endotoxin (EU/mg)	0.21	not determined
Method stated on certificate	YES	—	column, gradient and wavelength given

Section 5

Provenance and caveats

Where a sample came from changes the weight of the evidence. The index treats it as a first-class field.

Sample provenance: Buyer-sourced
Evidentiary weight: Strongest available evidence in this index.
Chain of custody: Retail purchase → submitter (−20 °C, 9 d) → laboratory (courier, dry ice, 8 d) → assay.
Assay date: 28 Aug 2025
Submitted to the index: 21 Sep 2025
Laboratory: Janoshik Analytical, Ostrava, Czechia
Method basis: 30 min gradient · high-resolution MS
Verification status: PARTIAL

What this report does not establish

That the material is free of bacterial endotoxin. Endotoxin was not measured. No chromatographic result bears on it.
That the material is sterile. Sterility was not tested.
A meaningful single purity number. The conjugate's polymer is polydisperse, so the "main peak" is a distribution rather than a peak, and an area-percent figure derived from it is not comparable to a synthetic peptide purity.
That any other vial in the same lot has the same composition. One vial was tested. Within-lot vial-to-vial variation in this index has a median of 0.28 pp and a 90th percentile of 0.74 pp.
That any other lot from the same supplier has the same composition. Batch-to-batch variation is larger than within-batch variation for every supplier here.
That the material is suitable for administration to a human or an animal. These are research compounds. No result on this site is a safety assessment and the index takes no position on use.
That the material was manufactured by the supplier that sold it. Contract synthesis is normal in this market and twenty-nine batches in the index fingerprint to a bulk from a different company than the one named on the label.

Section 6

Annotations 1

Signed technical comments from index contributors. Not a discussion forum — annotations question or contextualise the result, and the data team replies where a reply is warranted.

coa_reader21 Sep 2025

The supplier's own declaration is printed beside the index's balance on this page. Comparing the two is the point of publishing both and rule AX-R07 is about the comparison.

Section 7

Related records

Same batch — lot HJ-2507-S5943 n=9

Report	Lot	Lab	Quarter	Purity %	Water %	Recovery %	Provenance	Flags	Result
AX-2025-019906	HJ-2507-S5943	Kestrel	2025-Q3	98.54	7.23	—	Buyer-sourced	0	PASS
AX-2025-019907	HJ-2507-S5943	Janoshik	2025-Q3	98.20	6.75	—	Buyer-sourced	0	PASS
AX-2025-019908	HJ-2507-S5943	Janoshik	2025-Q3	98.16	7.25	104.1	Buyer-sourced	0	PASS
AX-2025-019909	HJ-2507-S5943	Janoshik	2025-Q3	97.65	7.04	—	Buyer-sourced	0	PASS
AX-2025-019910	HJ-2507-S5943	Medutest	2025-Q3	98.36	6.95	—	Buyer-sourced	1	FAIL
AX-2025-019912	HJ-2507-S5943	Janoshik	2025-Q3	97.70	7.08	—	Buyer-sourced	0	PASS
AX-2025-019913	HJ-2507-S5943	Nordanalyt	2025-Q3	98.33	6.64	—	Buyer-sourced	0	PASS
AX-2025-019914	HJ-2507-S5943	Medutest	2025-Q3	98.14	7.59	—	Buyer-sourced	0	PASS

Batch rollup and reproducibility assessment →

Cross-sections

Other recent PEG-MGF records in the index.
Report	Supplier	Lot	Lab	Quarter	Purity %	Water %	Recovery %	Provenance	Flags	Result
AX-2026-041821	ASY	ASY-{CAT}-2379	Janoshik	2026-Q2	98.57	5.79	95.3	Buyer-sourced	0	PASS
AX-2026-043577	SIG	SIG-2602-6794	Kestrel	2026-Q2	97.66	6.08	—	Buyer-sourced	0	PASS
AX-2026-043570	SIG	SIG-2602-6794	PeptideMeter	2026-Q2	97.76	5.45	104.2	Buyer-sourced	0	PASS
AX-2026-043569	SIG	SIG-2602-6794	PeptideMeter	2026-Q2	97.52	5.36	—	Laboratory-retained	0	PASS
AX-2026-043573	SIG	SIG-2602-6794	Janoshik	2026-Q2	98.58	4.79	104.2	Buyer-sourced	0	PASS
AX-2026-041822	ASY	ASY-{CAT}-2379	Janoshik	2026-Q2	98.83	6.51	—	Laboratory-retained	0	PASS
AX-2026-043574	SIG	SIG-2602-6794	Kestrel	2026-Q2	98.04	5.98	88.6	Buyer-sourced	1	MARGINAL
AX-2026-043576	SIG	SIG-2602-6794	Nordanalyt	2026-Q2	97.61	5.56	—	Buyer-sourced	0	PASS

Other recent HJ records in the index.
Report	Compound	Lot	Lab	Quarter	Purity %	Water %	Recovery %	Provenance	Flags	Result
AX-2026-042595	Semaglutide	HJ-2608-C7002	Janoshik	2026-Q3	99.50	3.55	—	Buyer-sourced	1	MARGINAL
AX-2026-042598	Semaglutide	HJ-2608-C7002	Janoshik	2026-Q3	99.59	3.84	—	Buyer-sourced	0	PASS
AX-2026-042605	Semaglutide	HJ-2608-C7002	Janoshik	2026-Q3	99.03	3.37	107.3	Buyer-sourced	0	PASS
AX-2026-042602	Semaglutide	HJ-2608-C7002	Nordanalyt	2026-Q3	99.21	3.50	92.0	Buyer-sourced	0	PASS
AX-2026-042603	Semaglutide	HJ-2608-C7002	Janoshik	2026-Q3	99.16	3.42	105.9	Buyer-sourced	0	PASS
AX-2026-042528	GHRP-6	HJ-2603-R5329	VendorInvestigate	2026-Q3	98.69	1.87	95.8	Buyer-sourced	0	FAIL
AX-2026-042526	GHRP-6	HJ-2603-R5329	Medutest	2026-Q3	99.37	3.06	—	Laboratory-retained	0	PASS
AX-2026-042527	GHRP-6	HJ-2603-R5329	VendorInvestigate	2026-Q3	99.21	2.77	93.2	Buyer-sourced	0	PASS